New radiation attack on chest tumors shows promise
Disease control
ENROLLING_BY_INVITATION
This early-phase trial tests a targeted radiation therapy called BNCT for people with recurrent chest tumors that cannot be surgically removed and have not responded to standard treatments. About 30 participants will receive a boron-based drug followed by neutron radiation to des…
Phase: PHASE1, PHASE2 • Sponsor: Stella Pharma Corporation • Aim: Disease control
Last updated May 15, 2026 11:53 UTC